Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Vyvgart Hytrulo
(EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT))Orphan drugstandardargenx US
Neonatal Fc Receptor Blocker [EPC]
12.1 Mechanism of Action VYVGART HYTRULO is a coformulation of efgartigimod alfa and hyaluronidase. Efgartigimod alfa is a human IgG1 antibody fragmen...
Browse all OBSOLETE: Channelopathy due to a neuronal acetylcholine receptor defect news →
View all OBSOLETE: Channelopathy due to a neuronal acetylcholine receptor defect specialists →